Floatz logo

.Gamma.-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-Octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-Octathio-

Delirium

Konkuk University Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Delirium cohort.

Asset / SponsorPhaseRating
Propofol
RenJi Hospital
Phase 4BB
Isoflurane
Duke University
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Pyridostigmine
Konkuk University Medical Center
Phase 4BB
Suvorexant
Mayo Clinic
Phase 4BB

View all 22 →

Same molecule, other indications

.Gamma.-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-Octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-Octathio- is also rated in:

neuromuscular junction diseaseDormant
A
Indicative · Phase 4
84 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative · Phase 4
69 / 100
View asset →
respiratory system disorderDormant
BB
Indicative · Phase 4
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →